These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6164609)

  • 1. Rheological and clotting changes in the immediate post-myocardial infarction period.
    Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheologic, coagulative parameters and study of fibrinolysis in patients with coronary heart disease before and after aorto-coronary by-pass (author's transl)].
    Brunetti A; Schivazappa L; Chioin R; Dalla Volta S; Valsecchi A; De Zio A; Salmaso L; Botti C; Girolami A
    G Ital Cardiol; 1978; 8(7):730-42. PubMed ID: 308020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorheologic parameters during the 6 months following myocardial infarct].
    Tóth K; Mezey B; Juricskay I; Simor T; Jávor T
    Orv Hetil; 1990 Apr; 131(14):727-30. PubMed ID: 2183141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological and clotting changes in chronic cor pulmonale.
    Dal Bo Zanon R; Saltarin P; Gribaldo R; Cafiero F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):844-52. PubMed ID: 6176510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The fibrinolysis system in recurrent myocardial infarction].
    Panchenko VM; Serebriakova TN; Podorol'skaia LV; Zhivoderov VM; Andreenko GV
    Sov Med; 1991; (3):3-5. PubMed ID: 1831932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood viscosity measurements in coronary infarct patients].
    Schäbitz J; Kohlmann U; Müller G
    Z Gesamte Inn Med; 1977 Jun; 32(12):283-5. PubMed ID: 910531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
    Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorrheological changes in ischemic heart disease].
    Forconi S; Guerrini M; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Di Perri T
    Ric Clin Lab; 1983; 13 Suppl 3():195-208. PubMed ID: 6672996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.
    Vonica A; Văgăonescu T; Cristea A; Stăncioiu N
    Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorrheologic parameters in myocardial infarct during the hospitalization phase].
    Tóth K; Bogár L; Simor T; Juricskay I; Jávor T
    Orv Hetil; 1990 Jan; 131(1):15-9. PubMed ID: 2105476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.
    Moyssakis I; Vlahodimitris IE; Kanakis MA; Kapsimali V; Tsoucala C; Vaiopoulos GA
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):670-3. PubMed ID: 20885133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases].
    Izaguirre Avila R; Ruiz de Chávez Cervantes A; Villavicencio R; Gómez Trigos A; Mar Chavira R; Spíndola Mdel C; Casanova JM
    Arch Inst Cardiol Mex; 1993; 63(3):235-40. PubMed ID: 8347053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.